The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Radiogenomics of Glioblastoma: Machine Learning–based Classification of Molecular Characteristics by Using Multiparametric and Multiregional MR Imaging Features
Abstract
Purpose To evaluate the association of multiparametric and multiregional magnetic resonance (MR) imaging features with key molecular characteristics in patients with newly diagnosed glioblastoma. Materials and Methods Retrospective data evaluation was approved by the local ethics committee, and the requirement to obtain informed consent was waived. Preoperative MR imaging features were correlated with key molecular characteristics within a single-institution cohort of 152 patients with newly diagnosed glioblastoma. Preoperative MR imaging features (n = 31) included multiparametric (anatomic and diffusion-, perfusion-, and susceptibility-weighted images) and multiregional (contrast-enhancing regions and hyperintense regions at nonenhanced fluid-attenuated inversion recovery imaging) information with histogram quantification of tumor volumes, volume ratios, apparent diffusion coefficients, cerebral blood flow, cerebral blood volume, and intratumoral susceptibility signals. Molecular characteristics determined included global DNA methylation subgroups (eg, mesenchymal, RTK I “PGFRA,” RTK II “classic”), MGMT promoter methylation status, and hallmark copy number variations (EGFR, PDGFRA, MDM4, and CDK4 amplification; PTEN, CDKN2A, NF1, and RB1 loss). Univariate analyses (voxel-lesion symptom mapping for tumor location, Wilcoxon test for all other MR imaging features) and machine learning models were applied to study the strength of association and discriminative value of MR imaging features for predicting underlying molecular characteristics. Results There was no tumor location predilection for any of the assessed molecular parameters (permutation-adjusted P > .05). Univariate imaging parameter associations were noted for EGFR amplification and CDKN2A loss, with both demonstrating increased Gaussian-normalized relative cerebral blood volume and Gaussian-normalized relative cerebral blood flow values (area under the receiver operating characteristics curve: 63%–69%, false discovery rate–adjusted P < .05). Subjecting all MR imaging features to machine learning–based classification enabled prediction of EGFR amplification status and the RTK II glioblastoma subgroup with a moderate, yet significantly greater, accuracy (63% for EGFR [P < .01], 61% for RTK II [P = .01]) than prediction by chance; prediction accuracy for all other molecular parameters was not significant. Conclusion The authors found associations between established MR imaging features and molecular characteristics, although not of sufficient strength to enable generation of machine learning classification models for reliable and clinically meaningful prediction of molecular characteristics in patients with glioblastoma. © RSNA, 2016 Online supplemental material is available for this article.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Building Predictive Models in R Using the caret Package
Kuhn, M. (2008) · Journal of Statistical Software · doi:10.18637/jss.v028.i05 · Cited by 8,863
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma
Patel, A. P., Tirosh, I., Trombetta, J. J., Shalek, A. K., Gillespie, S. M., Wakimoto, H., Cahill, D. P., Nahed, B. V., Curry, W. T., Martuza, R. L., et al. (2014) · Science · doi:10.1126/science.1254257 · Cited by 5,063
Wen, P. Y., Macdonald, D. R., Reardon, D. A., Cloughesy, T. F., Sorensen, A. G., Galanis, E., DeGroot, J., Wick, W., Gilbert, M. R., Lassman, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.3541 · Cited by 3,836
Self-citationSturm, D., Witt, H., Hovestadt, V., Khuong-Quang, D.-A., Jones, D. T. W., Konermann, C., Pfaff, E., Tönjes, M., Sill, M., Bender, S., et al. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.08.024 · Cited by 1,828
Self-citationMolecular determinants of the response of glioblastomas to EGFR kinase inhibitors
Mellinghoff, I. K., Wang, M. Y., Vivanco, I., Haas-Kogan, D. A., Zhu, S., Dia, E. Q., Lu, K. V., Yoshimoto, K., Huang, J. H. Y., Chute, D. J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa051918 · Cited by 1,442
Standards of care for treatment of recurrent glioblastoma—are we there yet?
Weller, M., Cloughesy, T., Perry, J. R., & Wick, W. (2013) · Neuro-Oncology · doi:10.1093/neuonc/nos273 · Cited by 771
Self-citationConsensus recommendations for a standardized Brain Tumor Imaging Protocol in clinical trials
(2015) · Neuro-Oncology · doi:10.1093/neuonc/nov095 · Cited by 663
Emerging insights into the molecular and cellular basis of glioblastoma
Dunn, G. P., Rinne, M. L., Wykosky, J., Genovese, G., Quayle, S. N., Dunn, I. F., Agarwalla, P. K., Chheda, M. G., Campos, B., Wang, A., et al. (2012) · Genes & Development · doi:10.1101/gad.187922.112 · Cited by 565
Identification of noninvasive imaging surrogates for brain tumor gene-expression modules
Diehn, M., Nardini, C., Wang, D. S., McGovern, S., Jayaraman, M., Liang, Y., Aldape, K., Cha, S., & Kuo, M. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801279105 · Cited by 440
Gutman, D. A., Cooper, L. A. D., Hwang, S. N., Holder, C. A., Gao, J., Aurora, T. D., Dunn, W. D., Scarpace, L., Mikkelsen, T., Jain, R., et al. (2013) · Radiology · doi:10.1148/radiol.13120118 · Cited by 420
Kim, H., Zheng, S., Amini, S. S., Virk, S. M., Mikkelsen, T., Brat, D. J., Grimsby, J., Sougnez, C., Muller, F., Hu, J., et al. (2015) · Genome Research · doi:10.1101/gr.180612.114 · Cited by 411
Bady, P., Sciuscio, D., Diserens, A.-C., Bloch, J., van den Bent, M. J., Marosi, C., Dietrich, P.-Y., Weller, M., Mariani, L., Heppner, F. L., et al. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1016-2 · Cited by 344
Dunn, J., Baborie, A., Alam, F., Joyce, K., Moxham, M., Sibson, R., Crooks, D., Husband, D., Shenoy, A., Brodbelt, A., et al. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605127 · Cited by 321
Glioblastoma Multiforme: Exploratory Radiogenomic Analysis by Using Quantitative Image Features
Gevaert, O., Mitchell, L. A., Achrol, A. S., Xu, J., Echegaray, S., Steinberg, G. K., Cheshier, S. H., Napel, S., Zaharchuk, G., & Plevritis, S. K. (2014) · Radiology · doi:10.1148/radiol.14131731 · Cited by 319
Aldape, K. D., Ballman, K., Furth, A., Buckner, J. C., Giannini, C., Burger, P. C., Scheithauer, B. W., Jenkins, R. B., & James, C. D. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.7.700 · Cited by 278
Itakura, H., Achrol, A. S., Mitchell, L. A., Loya, J. J., Liu, T., Westbroek, E. M., Feroze, A. H., Rodriguez, S., Echegaray, S., Azad, T. D., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa7582 · Cited by 272
Radiogenomic Mapping of Edema/Cellular Invasion MRI-Phenotypes in Glioblastoma Multiforme
Zinn, P. O., Majadan, B., Sathyan, P., Singh, S. K., Majumder, S., Jolesz, F. A., & Colen, R. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025451 · Cited by 265
Mabray, M. C., Barajas, R. F., & Cha, S. (2015) · Brain Tumor Research and Treatment · doi:10.14791/btrt.2015.3.1.8 · Cited by 237
Barajas, R. F., Phillips, J. J., Parvataneni, R., Molinaro, A., Essock-Burns, E., Bourne, G., Parsa, A. T., Aghi, M. K., McDermott, M. W., Berger, M. S., et al. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos128 · Cited by 224
Probabilistic Radiographic Atlas of Glioblastoma Phenotypes
Ellingson, B. M., Lai, A., Harris, R. J., Selfridge, J. M., Yong, W. H., Das, K., Pope, W. B., Nghiemphu, P. L., Vinters, H. V., Liau, L. M., et al. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3253 · Cited by 222
van Thuijl, H. F., Mazor, T., Johnson, B. E., Fouse, S. D., Aihara, K., Hong, C., Malmström, A., Hallbeck, M., Heimans, J. J., Kloezeman, J. J., et al. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1403-6 · Cited by 175
Grasbon-Frodl, E. M., Kreth, F. W., Ruiter, M., Schnell, O., Bise, K., Felsberg, J., Reifenberger, G., Tonn, J., & Kretzschmar, H. A. (2007) · International Journal of Cancer · doi:10.1002/ijc.23020 · Cited by 168
Pope, W. B., Chen, J. H., Dong, J., Carlson, M. R. J., Perlina, A., Cloughesy, T. F., Liau, L. M., Mischel, P. S., Nghiemphu, P. L., Lai, A., et al. (2008) · Radiology · doi:10.1148/radiol.2491072000 · Cited by 149
Ellingson, B. M. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-014-0506-0 · Cited by 132
Carlson, M. R. J., Pope, W. B., Horvath, S., Braunstein, J. G., Nghiemphu, P. L., Tso, C.-L., Mellinghoff, I. K., Lai, A., Liau, L. M., Mischel, P. S., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2772 · Cited by 118
Naeini, K. M., Pope, W. B., Cloughesy, T. F., Harris, R. J., Lai, A., Eskin, A., Chowdhury, R., PHILLIPS, H. S., Nghiemphu, P. L., Behbahanian, Y., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not008 · Cited by 104
Wiestler, B., Capper, D., Hovestadt, V., Sill, M., Jones, D., Hartmann, C. J., Felsberg, J., Platten, M., Feiden, W., Keyvani, K., et al. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou138 · Cited by 89
Self-citationPope, W. B., Mirsadraei, L., Lai, A., Eskin, A., Qiao, J. X., Kim, H. J., Ellingson, B. M., Nghiemphu, P. L., Kharbanda, S., Soriano, R. H., et al. (2012) · American Journal of Neuroradiology · doi:10.3174/ajnr.a2917 · Cited by 72
P14ARF inhibits human glioblastoma–induced angiogenesis by upregulating the expression of TIMP3
Zerrouqi, A., Pyrzynska, B., Febbraio, M., Brat, D. J., & Van Meir, E. G. (2012) · Journal of Clinical Investigation · doi:10.1172/jci38596 · Cited by 70
Colen, R. R., Vangel, M. G., Wang, J., Gutman, D. A., Hwang, S. N., Wintermark, M., Jain, R., Nicolas‐Jilwan, M., Chen, J. Y., Raghavan, P., et al. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-30 · Cited by 69
Perez, J. A., Thomas, A. A., Kaley, T. J., Lyo, J. K., Peck, K. K., Holodny, A. I., Mellinghoff, I. K., Shi, W., Zhang, Z., & Young, R. J. (2015) · American Journal of Neuroradiology · doi:10.3174/ajnr.a4484 · Cited by 53
Genomics of Brain Tumor Imaging
Pope, W. B. (2014) · Neuroimaging Clinics of North America · doi:10.1016/j.nic.2014.09.006 · Cited by 40
Cited by
Artificial intelligence in cancer imaging: Clinical challenges and applications
Bi, W. L., Hosny, A., Schabath, M. B., Giger, M. L., Birkbak, N. J., Mehrtash, A., Allison, T., Arnaout, O., Abbosh, C., Dunn, I. F., et al. (2019) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21552 · Cited by 1,846
A deep learning-based radiomics model for prediction of survival in glioblastoma multiforme
Lao, J., Chen, Y., Li, Z.-C., Li, Q., Zhang, J., Liu, J., & Zhai, G. (2017) · Scientific Reports · doi:10.1038/s41598-017-10649-8 · Cited by 630
Radiogenomics: bridging imaging and genomics
Bodalal, Z., Trebeschi, S., Nguyen-Kim, T. D. L., Schats, W., & Beets-Tan, R. (2019) · Abdominal Radiology · doi:10.1007/s00261-019-02028-w · Cited by 310
Park, J. E., Kim, D., Kim, H. S., Park, S. Y., Kim, J. Y., Cho, S. J., Shin, J. H., & Kim, J. H. (2020) · European Radiology · doi:10.1007/s00330-019-06360-z · Cited by 282
Continuous Learning AI in Radiology: Implementation Principles and Early Applications
Pianykh, O. S., Langs, G., Dewey, M., Enzmann, D. R., Herold, C. J., Schoenberg, S. O., & Brink, J. A. (2020) · Radiology · doi:10.1148/radiol.2020200038 · Cited by 237
Metadata
- Authors
- Kickingereder, P., Bonekamp, D., Nowosielski, M., Kratz, A., Sill, M., Burth, S., Wick, A., Eidel, O., Schlemmer, H.-P., Radbruch, A., Debus, J., Herold-Mende, C., Unterberg, A., Jones, D., Pfister, S., Wick, W., von Deimling, A., Bendszus, M., & Capper, D.
- Venue
- Radiology
- Published
- 2016-12
- Volume
- 281
- Issue
- 3
- Pages
- 907-918
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2519238003
- Cited by
- 305
- References
- 33
- FWCI
- 18.42
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.